Coming soon.

Upload a Poster PDF for publication and Audio Tour by Friday, February 24th in the Poster Presenter Portal.  Instructions were sent on December 20th. Posters will be available on the meeting website and the meeting App.

See Poster and Audio Tour Guidelines

Printed Poster Instructions:

• The maximum poster size is 44" x 44" (112cm x 112cm)
• A section at the top of the poster must contain the poster number, title, all authors, and their affiliations.
• As the official meeting language is English, all poster presentations are to be in English.
• Advertising of products is prohibited.
• Patient anonymity must be ensured at all times.
• It is the author’s responsibility to ensure that all parts of the poster (tables) are free of any third party right and/or cited correctly.

Poster Printing Service

We are offering a poster printing service which delivers the printed poster to the Poster Attendant desk in the Exhibit Hall. See poster printing service.  Please choose the first item on the list of sizes.

• Go to: www.shepardes.com/posters
• Find your event name: ACMG Annual Clinical Genetics Meeting
• Login using your email address (this is the same contact email you provided to show management).
• Enter in password: ACMG23
• Choose your poster size: CODE SIZE PRICE - 70100 42" x 36" $164.10
• Reference Shepard’s Graphic Guidelines to ensure your artwork is in the correct format.
• Upload your graphics to the order.
• Proceed to checkout.
  NOTE: Orders will be processed when credit cards payments are entered and accepted.
• When you arrive on-site, go to the Shepard Service Center during exhibit move-in hours to pick up your poster.

• Poster withdrawal is Friday, February 10. A written request to withdraw must be submitted to Education@ACMG.net if the first author decides to withdraw the abstract

• Poster presenters must be at their poster during assigned times below.

All meeting attendees, presenters, authors, the media, exhibitors, institutions, industry and all other organizations and individuals are required to abide by the ACMG Annual Meeting Embargo Policy.

All abstracts, posters and oral (platform) scientific presentations are under strict embargo once ACMG has notified a presenter of their abstract’s acceptance.

An embargo means that information from any abstract, poster or presentation is confidential and may not be announced, publicized, or disseminated before the embargo lift dates and times, as detailed below. The purpose of the ACMG Embargo Policy below is to protect the scientific integrity of all content presented at the ACMG Annual Clinical Genetics meeting and to ensure publicity is not released prematurely.

All ACMG Annual Clinical Genetics Meeting content to be presented or published is embargoed until the time of an actual conference presentation. ACMG has updated its guidelines to reflect the current e-publishing and online environment. The Embargo Policy below provides more details regarding the types of content that are embargoed.

The ACMG Embargo Policy is based on trust. Violation of the ACMG Embargo Policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate may be taken. Media who violate the Embargo Policy may lose their ACMG press credentials and be removed from the list to receive embargoed copies of ACMG news releases.

Specific Embargo Dates and Times:
Abstracts – Embargoed until February 10, 2023; posted on the ACMG Meeting website

Accepted abstracts will be made available online in advance of the ACMG Annual Clinical Genetics Meeting and will also be published in a special online supplement to our official open access journal, Genetics in Medicine Open. The information contained in abstracts is embargoed until the abstracts are available and published online. Information contained in abstracts may not be released in any format, including preprints, until the abstracts appear online.

ACMG continues to require that any information that goes beyond that contained in the submitted abstract is under embargo until the times specified below.

Posters – Embargoed until Wednesday, March 15, 2023, at 5:00 pm MT
For abstracts selected for posters, the embargo will lift when the e-posters are published via ACMG.

Oral (Platform) Scientific Presentations – Presentations embargoed until start of live session

The embargo for all scientific presentations will lift at the start time of the session in which the live presentation is being made. Interviews with presenters as well as any information to be presented for the first time at the ACMG Annual Meeting are embargoed until the time of the live presentation in which the paper will be given.

For questions about the ACMG embargo policy, email education@acmg.net.

Completion of all required information in the online abstract submission system serves as an agreement. It certifies the ACMG abstract submitter's understanding of the rules for participation contained in the online abstract submission program.

• Each abstract author agrees and certifies that he or she:
  o    has read all of the rules and agrees to be bound by them,
  o    is responsible for submission of the abstract in accordance with the rules, and
  o    waives any and all claims against ACMG and any reviewer arising out of or relating to the abstract submission and review process, including, but not limited to peer review and the grading of abstracts.

Financial Disclosure Policy (to be completed by Platform Presenter)
The American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to the improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.

ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias. The Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all relevant financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.
*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Standard to Prevent Commercial Bias and Marketing in Accredited Continuing Education
ACCME requirements designed to ensure that CME activities are independent and free of commercial bias.

Accredited continuing education must protect learners from commercial bias and marketing.

The accredited provider must ensure that all decisions related to the planning, faculty selection, delivery, and evaluation of accredited education are made without any influence or involvement from the owners and employees of an ineligible company.

Accredited education must be free of marketing or sales of products or services. Faculty must not actively promote or sell products or services that serve their professional or financial interests during accredited education.

The accredited provider must not share the names or contact information of learners with any ineligible company or its agents without the explicit consent of the individual learner.

Platform Presenters' Responsibility Regarding Financial Disclosure (ACCME Compliance)

• The presenting author for a platform presentation will be contacted and must complete the online financial disclosure form and additional items pertaining to their presentation and participation.
• Employees of ACCME defined ineligible company may not present an accredited platform presentation.
• The content of the information with which you are involved will promote quality in health care or advances in science and will not promote a specific proprietary or commercial interest. Content for this publication will be well-balanced and unbiased.

ACMG Education Policies
Please review the policies below regarding the ACMG Education program

• Financial Disclosures and Mitigation Procedure
• ACMG Content Validation Policy
• ACMG Content Branding Policy

Completion of all required information in the online abstract submission system serves as an agreement. It certifies the ACMG abstract submitter's understanding of the rules for participation contained in the online abstract submission program and affirms that:

1. All authors approve of submitting this work for presentation and publication;
2. The author(s) transfer(s) all copyright ownership of the named abstract to the American College of Medical Genetics and Genomics (except when one or more authors are U.S. Government employees);
3. Submitter is acting on behalf of authors and has read the ACMG Conflict-of-Interest Policy and has acted in accordance with that policy;
4. The author(s) agree(s) to materially confine the presentation to information in the abstract, if accepted for presentation. If an author has more than one abstract accepted, each presentation will be materially confined to the information in the abstract selected for the specific session;
5. The presenting author will be available to present the abstract if selected for the program. The author(s) will immediately notify ACMG if the first author is not the presenting author. Presenting author will be required to complete presenter documents including financial disclosure.

Contact Information
Send related correspondence and questions regarding abstract submissions or notifications to education@acmg.net.

Please note that submitting an abstract does not register you for the ACMG Annual Meeting. View rates, deadlines and register here.